Antibody Library Technology Market

Antibody Library Technology Comprehensive Study by Type (Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Surface Display), End-User (Biopharmaceutical Companies, Contract Research Organization, Academic & Research Institutes) Players and Region - Global Market Outlook to 2030

Antibody Library Technology Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Antibody Library Technology
Antibody libraries are created using genomic data coding for antibody variable domains, which can be obtained from naive donors of immune B cells. By attaching the coding sequence of scFv or Fab to the coat protein, antibodies were the first proteins to be successfully shown on the surface of the phage. Antibody libraries are created using a variety of technologies. The global antibody library technologies market was born as a result of this. Antibodies, which are well-known targeted therapy agents, are in great demand because to the growing need for highly targeted medicines to treat ailments such as cancer, uncommon diseases, and neurological disorders. Antibody therapy is becoming more widely used as a result of increased demand for greater precision, particularly in drug discovery. Target identification and validation are the first steps in drug development, and antibodies are the gold standard for detecting a specific biomolecule or biological pathway. Antibody library technology is also becoming more popular as a result of technical improvements, the need for therapeutic antibodies, and the demand for research automation.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The Market is highly competitive with several players present in the market. Companies in the antibody library technology industry are pursuing strategic partnerships with academic institutions in order to bridge the gap between early scientific discovery and translation into novel therapeutics. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Antibody Library Technology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

MorphoSys AG (Germany), Abzena Plc.(United States), XOMA Corporation(United States), AvantGen Inc.(United States), Creative-biolabs (United States), AbChecks.r.o. (Czech Republic), Philogen S.p.A. (Italy), AnaptysBio, Inc.(United States), Abgent Inc. (United States), Vaccinex Inc.(United States) and AxioMx Inc.(United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Adimab LLC (United States) and Invenra Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Antibody Library Technology market by Type (Phage Display, Ribosome Display, Yeast Display and Mammalian Cell Surface Display) and Region.



On the basis of geography, the market of Antibody Library Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User, the sub-segment i.e. Biopharmaceutical Companies will boost the Antibody Library Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
New Display-Less Technology

Market Growth Drivers:
Increased Drug Discovery and Development Activities and Demand for Better Precision Using Antibody Therapy

Challenges:
Conventional Molecular Display Technologies Have Limitations and Shortcomings

Restraints:
Difficulties related to Sample Collection

Opportunities:
Increased R&D by Companies, Pharmaceutical and Biotechnological Companies Are Trying to Add Antibodies to Their Pipeline to Mitigate Patent Expiry and Partnerships Between Technology Developers and Companies that Already have Therapeutic Antibody Development

Market Leaders and their expansionary development strategies
In February 2021: RxCelerate, a leading international out-sourced drug discovery and development platform announced to launched a new antibody discovery platform, Galaxy™, that offers significant advantages over the current generation of tools for delivery of new therapeutic monoclonal antibodies.
April 2020 – Avantgen developed and launched Novel Human Antibodies “mAbs” to diagnose SARS-COV-2 Infection and treat COVID-19. and September 2020 – Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma


Key Target Audience
Drug Companies, Healthcare Industry, Medical Research Companies and Regulatory Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Phage Display
  • Ribosome Display
  • Yeast Display
  • Mammalian Cell Surface Display
By End-User
  • Biopharmaceutical Companies
  • Contract Research Organization
  • Academic & Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Drug Discovery and Development Activities
      • 3.2.2. Demand for Better Precision Using Antibody Therapy
    • 3.3. Market Challenges
      • 3.3.1. Conventional Molecular Display Technologies Have Limitations and Shortcomings
    • 3.4. Market Trends
      • 3.4.1. New Display-Less Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Library Technology, by Type, End-User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Antibody Library Technology (Value)
      • 5.2.1. Global Antibody Library Technology by: Type (Value)
        • 5.2.1.1. Phage Display
        • 5.2.1.2. Ribosome Display
        • 5.2.1.3. Yeast Display
        • 5.2.1.4. Mammalian Cell Surface Display
      • 5.2.2. Global Antibody Library Technology by: End-User (Value)
        • 5.2.2.1. Biopharmaceutical Companies
        • 5.2.2.2. Contract Research Organization
        • 5.2.2.3. Academic & Research Institutes
      • 5.2.3. Global Antibody Library Technology Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Antibody Library Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. MorphoSys AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abzena Plc.(United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. XOMA Corporation(United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AvantGen Inc.(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Creative-biolabs (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AbChecks.r.o. (Czech Republic)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Philogen S.p.A. (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AnaptysBio, Inc.(United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Abgent Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vaccinex Inc.(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. AxioMx Inc.(United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Antibody Library Technology Sale, by Type, End-User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Antibody Library Technology (Value)
      • 7.2.1. Global Antibody Library Technology by: Type (Value)
        • 7.2.1.1. Phage Display
        • 7.2.1.2. Ribosome Display
        • 7.2.1.3. Yeast Display
        • 7.2.1.4. Mammalian Cell Surface Display
      • 7.2.2. Global Antibody Library Technology by: End-User (Value)
        • 7.2.2.1. Biopharmaceutical Companies
        • 7.2.2.2. Contract Research Organization
        • 7.2.2.3. Academic & Research Institutes
      • 7.2.3. Global Antibody Library Technology Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Library Technology: by Type(USD Million)
  • Table 2. Antibody Library Technology Phage Display , by Region USD Million (2018-2023)
  • Table 3. Antibody Library Technology Ribosome Display , by Region USD Million (2018-2023)
  • Table 4. Antibody Library Technology Yeast Display , by Region USD Million (2018-2023)
  • Table 5. Antibody Library Technology Mammalian Cell Surface Display , by Region USD Million (2018-2023)
  • Table 6. Antibody Library Technology: by End-User(USD Million)
  • Table 7. Antibody Library Technology Biopharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 8. Antibody Library Technology Contract Research Organization , by Region USD Million (2018-2023)
  • Table 9. Antibody Library Technology Academic & Research Institutes , by Region USD Million (2018-2023)
  • Table 10. South America Antibody Library Technology, by Country USD Million (2018-2023)
  • Table 11. South America Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 12. South America Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 13. Brazil Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 14. Brazil Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 15. Argentina Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 16. Argentina Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 17. Rest of South America Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 19. Asia Pacific Antibody Library Technology, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 22. China Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 23. China Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 24. Japan Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 25. Japan Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 26. India Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 27. India Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 28. South Korea Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 29. South Korea Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 30. Taiwan Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 31. Taiwan Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 32. Australia Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 33. Australia Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 36. Europe Antibody Library Technology, by Country USD Million (2018-2023)
  • Table 37. Europe Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 38. Europe Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 39. Germany Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 40. Germany Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 41. France Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 42. France Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 43. Italy Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 44. Italy Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 45. United Kingdom Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 47. Netherlands Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 48. Netherlands Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 49. Rest of Europe Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 51. MEA Antibody Library Technology, by Country USD Million (2018-2023)
  • Table 52. MEA Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 53. MEA Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 54. Middle East Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 55. Middle East Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 56. Africa Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 57. Africa Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 58. North America Antibody Library Technology, by Country USD Million (2018-2023)
  • Table 59. North America Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 60. North America Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 61. United States Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 62. United States Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 63. Canada Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 64. Canada Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 65. Mexico Antibody Library Technology, by Type USD Million (2018-2023)
  • Table 66. Mexico Antibody Library Technology, by End-User USD Million (2018-2023)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Antibody Library Technology: by Type(USD Million)
  • Table 79. Antibody Library Technology Phage Display , by Region USD Million (2025-2030)
  • Table 80. Antibody Library Technology Ribosome Display , by Region USD Million (2025-2030)
  • Table 81. Antibody Library Technology Yeast Display , by Region USD Million (2025-2030)
  • Table 82. Antibody Library Technology Mammalian Cell Surface Display , by Region USD Million (2025-2030)
  • Table 83. Antibody Library Technology: by End-User(USD Million)
  • Table 84. Antibody Library Technology Biopharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 85. Antibody Library Technology Contract Research Organization , by Region USD Million (2025-2030)
  • Table 86. Antibody Library Technology Academic & Research Institutes , by Region USD Million (2025-2030)
  • Table 87. South America Antibody Library Technology, by Country USD Million (2025-2030)
  • Table 88. South America Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 89. South America Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 90. Brazil Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 91. Brazil Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 92. Argentina Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 93. Argentina Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 94. Rest of South America Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 95. Rest of South America Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 96. Asia Pacific Antibody Library Technology, by Country USD Million (2025-2030)
  • Table 97. Asia Pacific Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 98. Asia Pacific Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 99. China Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 100. China Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 101. Japan Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 102. Japan Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 103. India Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 104. India Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 105. South Korea Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 106. South Korea Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 107. Taiwan Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 108. Taiwan Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 109. Australia Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 110. Australia Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 111. Rest of Asia-Pacific Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 112. Rest of Asia-Pacific Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 113. Europe Antibody Library Technology, by Country USD Million (2025-2030)
  • Table 114. Europe Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 115. Europe Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 116. Germany Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 117. Germany Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 118. France Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 119. France Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 120. Italy Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 121. Italy Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 122. United Kingdom Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 123. United Kingdom Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 124. Netherlands Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 125. Netherlands Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 126. Rest of Europe Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 127. Rest of Europe Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 128. MEA Antibody Library Technology, by Country USD Million (2025-2030)
  • Table 129. MEA Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 130. MEA Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 131. Middle East Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 132. Middle East Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 133. Africa Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 134. Africa Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 135. North America Antibody Library Technology, by Country USD Million (2025-2030)
  • Table 136. North America Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 137. North America Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 138. United States Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 139. United States Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 140. Canada Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 141. Canada Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 142. Mexico Antibody Library Technology, by Type USD Million (2025-2030)
  • Table 143. Mexico Antibody Library Technology, by End-User USD Million (2025-2030)
  • Table 144. Research Programs/Design for This Report
  • Table 145. Key Data Information from Secondary Sources
  • Table 146. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Library Technology: by Type USD Million (2018-2023)
  • Figure 5. Global Antibody Library Technology: by End-User USD Million (2018-2023)
  • Figure 6. South America Antibody Library Technology Share (%), by Country
  • Figure 7. Asia Pacific Antibody Library Technology Share (%), by Country
  • Figure 8. Europe Antibody Library Technology Share (%), by Country
  • Figure 9. MEA Antibody Library Technology Share (%), by Country
  • Figure 10. North America Antibody Library Technology Share (%), by Country
  • Figure 11. Global Antibody Library Technology share by Players 2023 (%)
  • Figure 12. Global Antibody Library Technology share by Players (Top 3) 2023(%)
  • Figure 13. Global Antibody Library Technology share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. MorphoSys AG (Germany) Revenue, Net Income and Gross profit
  • Figure 16. MorphoSys AG (Germany) Revenue: by Geography 2023
  • Figure 17. Abzena Plc.(United States) Revenue, Net Income and Gross profit
  • Figure 18. Abzena Plc.(United States) Revenue: by Geography 2023
  • Figure 19. XOMA Corporation(United States) Revenue, Net Income and Gross profit
  • Figure 20. XOMA Corporation(United States) Revenue: by Geography 2023
  • Figure 21. AvantGen Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 22. AvantGen Inc.(United States) Revenue: by Geography 2023
  • Figure 23. Creative-biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 24. Creative-biolabs (United States) Revenue: by Geography 2023
  • Figure 25. AbChecks.r.o. (Czech Republic) Revenue, Net Income and Gross profit
  • Figure 26. AbChecks.r.o. (Czech Republic) Revenue: by Geography 2023
  • Figure 27. Philogen S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 28. Philogen S.p.A. (Italy) Revenue: by Geography 2023
  • Figure 29. AnaptysBio, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 30. AnaptysBio, Inc.(United States) Revenue: by Geography 2023
  • Figure 31. Abgent Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abgent Inc. (United States) Revenue: by Geography 2023
  • Figure 33. Vaccinex Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 34. Vaccinex Inc.(United States) Revenue: by Geography 2023
  • Figure 35. AxioMx Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 36. AxioMx Inc.(United States) Revenue: by Geography 2023
  • Figure 37. Global Antibody Library Technology: by Type USD Million (2025-2030)
  • Figure 38. Global Antibody Library Technology: by End-User USD Million (2025-2030)
  • Figure 39. South America Antibody Library Technology Share (%), by Country
  • Figure 40. Asia Pacific Antibody Library Technology Share (%), by Country
  • Figure 41. Europe Antibody Library Technology Share (%), by Country
  • Figure 42. MEA Antibody Library Technology Share (%), by Country
  • Figure 43. North America Antibody Library Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • MorphoSys AG (Germany)
  • Abzena Plc.(United States)
  • XOMA Corporation(United States)
  • AvantGen Inc.(United States)
  • Creative-biolabs (United States)
  • AbChecks.r.o. (Czech Republic)
  • Philogen S.p.A. (Italy)
  • AnaptysBio, Inc.(United States)
  • Abgent Inc. (United States)
  • Vaccinex Inc.(United States)
  • AxioMx Inc.(United States)
Additional players considered in the study are as follows:
Adimab LLC (United States) , Invenra Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 219 Pages 97 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Antibody Library Technology Market Quantitative research analysis
Antibody Library Technology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as MorphoSys AG (Germany), Abzena Plc.(United States), XOMA Corporation(United States), AvantGen Inc.(United States), Creative-biolabs (United States), AbChecks.r.o. (Czech Republic), Philogen S.p.A. (Italy), AnaptysBio, Inc.(United States), Abgent Inc. (United States), Vaccinex Inc.(United States) and AxioMx Inc.(United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"New Display-Less Technology" is seen as one of major influencing trends for Antibody Library Technology Market during projected period 2023-2030.
The Antibody Library Technology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Antibody Library Technology Market Report?

Have a Query? Click Here

Other Related Reports

Endobronchial Ultrasound Biopsy Device Comprehensive Study by Type (EBUS-TBNA, Bronchoscopes and probes, Biopsy forceps and needles, Ultrasound processor and needles, Cytology brushes and spray cathe...
$ 3650
Connected RHM Comprehensive Study by Type (Single Parameter Monitoring System, Multi-Parameter Monitoring System), Application (Disease Monitoring, Vital Signs Monitoring, Wellness Management, Others...
$ 3650
Energy-based Skin Tightening Comprehensive Study by Application (Wrinkle Reduction, Face Lifting, Body Lifting, Anti-Ageing, Others), End-User (Dermatology Clinics, Hospitals, Beauty Salons, Cosmetic...
$ 3500
Artificial Intelligence In Genomics Comprehensive Study by Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & Animal Research, Other), Technology (Deep Learning...
$ 3750
Patient Self-Service Kiosks Comprehensive Study by Type (Digital Display System, Internet), Application (Appointment Booking, Co-Payment Collection, Information Updating, Self-Check In, Others), End-...
$ 3650
Dental Regeneration Comprehensive Study by Application (Dentin, Enamel, Pulp), Demographic (Paediatric, Adult, Geriatric), End-User (Hospitals, Dental Clinics, Ambulatory Care Centers) Players and Re...
$ 3500